|1.||Kundi, Michael: 2 articles (09/2006 - 04/2005)|
|2.||Szalai, Krisztina: 2 articles (09/2006 - 04/2005)|
|3.||Schöll, Isabella: 2 articles (09/2006 - 04/2005)|
|4.||Jensen-Jarolim, Erika: 2 articles (09/2006 - 04/2005)|
|5.||Untersmayr, Eva: 2 articles (09/2006 - 04/2005)|
|6.||Nogi, Koji: 2 articles (01/2002 - 01/2002)|
|7.||Taniguchi, Hiroyuki: 2 articles (01/2002 - 01/2002)|
|8.||Onoda, Yuichi: 2 articles (01/2002 - 01/2002)|
|9.||Kim, Eun-Hee: 1 article (02/2014)|
|10.||Park, Jong-Min: 1 article (02/2014)|
|1.||Stomach Ulcer (Gastric Ulcer)
01/01/1990 - "Scopolia drugs were found to be effective anti-ulcer agents in three experimental gastric ulcer models (i.e. "
01/01/1984 - "[Efficacy of anti-ulcer agents judged from background factors of stomach ulcer]."
02/15/2014 - "Clinical treatments for gastric ulcer have allowed the rapid development of potent anti-ulcer drugs during the last several decades. "
08/01/2010 - "The aetiology of gastric ulcers is not completely understood and continuous use of anti-ulcer agents leads to many side effects. "
01/01/2003 - "It was discovered that patients with stomach ulcers take anti-ulcer drugs while standing, sitting, lying, or moving in the space. "
|2.||Duodenal Ulcer (Curling's Ulcer)
01/01/1988 - "The efficacy of various antimicrobial and anti-ulcer agents on the elimination of Campylobacter pylori in duodenal ulcer patients was investigated. "
03/01/1977 - "This method of producing duodenal ulcers may sufficiently resemble the clinical situation to provide a model for the study of anti-ulcer drugs and the natural history of duodenal ulcers."
07/01/2000 - "This communication reviews the salient pharmacology of the novel anti-ulcer drugs currently in development, with particular emphasis on the treatment of gastric and duodenal ulcers. "
01/01/1996 - "Simultaneous evaluation of gastric and duodenal ulcers-healing activities of anti-ulcer agents in rats."
01/01/1996 - "In conclusion, this experimental chronic ulcer model in rats is useful for directly comparing the effects of anti-ulcer drugs on the healing of gastric and duodenal ulcers. "
05/15/2004 - "In addition, uncertainties regarding the clinical efficacy of anti-ulcer drugs and cyclo-oxygenase-2 inhibitors against non-steroidal anti-inflammatory drug-related ulcer complications are put into perspective. "
05/15/2004 - "Current recommendations regarding strategies using anti-ulcer drugs and cyclo-oxygenase-2 inhibitors for prevention of clinical non-steroidal anti-inflammatory drug upper gastrointestinal events are largely derived from studies using surrogates such as endoscopic ulcers, erosions, and symptoms in low- to average-risk patients. "
03/01/1995 - "The therapeutic approaches for the treatment and prevention of NSAID-induced ulcers is critically reviewed using data derived from carefully controlled, world-wide clinical studies with anti-ulcer drugs. "
02/01/2010 - "Available anti-ulcer drugs although effective at various steps of ulcer pathogenecity, pose adverse effects. "
10/21/2007 - "In addition, SRPP is non-toxic as opposed to other known anti-ulcer drugs, and therefore may be employed as a potential alternative for ulcer management."
|4.||Peptic Ulcer (Peptic Ulcers)
02/01/1999 - "In this observational study, a Poisson multiple regression model was used to compare changes, after policy implementation, in Medicaid reimbursement for prescription anti-ulcer drugs as well as hospitalization rates between pre- and post-implementation periods in Medicaid versus non-Medicaid patients hospitalized with peptic ulcer disease. "
06/01/2003 - "The anti-ulcer drugs included all drug items of the group A02B (drugs for treatment of peptic ulcer) in the Anatomical Therapeutic Chemical classification system (version 2000). "
10/01/2001 - "Most gastroduodenal ulcers heal over time, albeit more slowly, with conventional doses of any of the available anti-ulcer drugs. "
06/15/1994 - "This finding should be taken into consideration in the development of new anti ulcer drugs, as HOCl is a detrimental factor in the pathophysiology of gastroduodenal ulcers."
04/07/1990 - "Since the introduction of potent anti-ulcer drugs the number of elective operations for peptic ulcer (PU) has decreased considerably, whereas the number of emergency operations has remained largely unchanged. "
08/01/2012 - "To analyse trends in the incidence of hospitalisation due to upper gastrointestinal bleeding (UGB) and the relationship with the prescribing of anti-ulcer agents. "
08/01/2012 - "[Evaluation of the incidence of upper gastrointestinal bleeding in Spain in relation to the taking of anti-ulcer agents]."
09/01/2009 - ""Occasional" oral NSAID use is an important step leading to variceal hemorrhage, especially in FV, even if the mucosa is protected by anti-ulcer drugs. "
10/01/1991 - "This study was undertaken to ascertain whether the modern effective anti-ulcer drugs have had any influence on the natural history of hemorrhagic peptic ulcer disease and other acid-related gastroduodenal bleeding disorders. "
09/01/2009 - "Interactions between anti-ulcer drugs and non-steroidal anti-inflammatory drugs in cirrhotic patients with bleeding esophagogastric varices."
|1.||Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
|2.||Proton Pump Inhibitors
|3.||Aspirin (Acetylsalicylic Acid)
|10.||Ethanol (Ethyl Alcohol)
|1.||Drug Administration Schedule